Results of Using Selective Endotoxin Adsorption in Cancer Patients with Sepsis
https://doi.org/10.15360/1813-9779-2014-6-32-38
Abstract
Objective: to study the clinical efficiency of using selective lipopolysaccharide (LPS) adsorption in postoperative gram negative sepsis in cancer patients.
Subjects and methods. Examinations were made in 47 patients (11 women and 36 men) aged 47 to 84 years, who had been operated on for cancer and whose postoperative period had been complicated by gramnegative sepsis. The patients were divided into 2 groups: 1) 15 patents who received standard therapy (a control group); 2) 32 who had LPS adsorption using immobilized polymyxin B (a study group).
Results. Upon completion of the selective LPS adsorption program, there was regression of the clinical signs of sepsis, statistically significantly lower peripheral blood leukocyte and neutrophil levels, and better blood biochemical parameters in 87.5% of cases. High baseline endotox in activity decreased from >0.6 to <0.4 units in 89% of the patients. After the final session of LPS adsorption, the need for vasopressor support reduced due to hemodynamic profile optimization. After selective endotoxin adsorption cycles, 15 of 26 cases did not need to continue organ replacement therapy. Twentyeightday mortality rates in the study and control groups were 25.0 and 53.3%, respectively.
Conclusion. Incorporation of LPS adsorption into a set of intensive therapy for gramnegative sepsis is pathogenetically substantiated and can effectively abolish the manifestations of the systemic effects of bacterial endotoxin. The early and timely use of LPS adsorption provides inhibition of an initiating stimulus, which makes it possible to prevent the progression of a septic process and the development of severe sepsis and septic shock and improves the results of therapy in cancer inpatients.
About the Authors
N. D. UshakovaRussian Federation
A. N. Shevchenko
Russian Federation
M. V. Chetverikov
Russian Federation
E. Yu. Zlatnik
Russian Federation
T. A. Zykova
Russian Federation
References
1. Beloborodova N.V. Integratsiya metabolizma cheloveka i ego mikrobioma pri kriticheskikh sostoyaniyakh. Obshchaya Reanimatologiya. [Integration of metabolism in man and his microbiome in critical conditions. General Reanimatology]. 2012; 8 (4): 42–54. http://dx.doi.org/ 10.15360/181397792012442. [In Russ.]
2. Mlinnik R.A., Voennov O.V. Vliyanie metodov detoksikatsii na gazoobmennuyu funktsiyu legkikh u patsientov s rasprostranennym peritonitom. Obshchaya Reanimatologiya. [Impact of detoxification techniques on pulmonary gas exchange function in patients with generalized peritonitis. General Reanimatology]. 2012; 8 (2): 38–42. http://dx.doi.org/10.15360/181397792012238. [In Russ.]
3. Moroz V.V., Kuzovlev A.N., Polovnikov S.G., Stets V.V., Varvarin V.V. Ingalyatsionnyi tobramitsin v lechenii tyazhelykh nozokomialnykh pnevmonii. Obshchaya Reanimatologiya. [Inhaled tobramycin in the treatment of severe nosocomial pneumonias. General Reanimatology]. 2012; 8 (2): 5–10. http://dx.doi.org/10.15360/18139779201225. [In Russ.]
4. Shabanov A.K., Khubutiya M.Sh., Bulava G.V., Beloborodova N.V., Kuzovlev A.N., Grebenchikov O.A., Kosolapov D.A., Shpitonkov M.I. Dinamika urovnya prokaltsitonina pri razvitii nozokomialnoi pnevmonii u postradavshikh s tyazheloi sochetannoi travmoi v otdelenii reanimatsii. Obshchaya Reanimatologiya. [Time course of changes in the level of procalcitonin in the development of nosocomial pneumonia in victims with severe concomitant injury in an intensive care unit. General Reanimatology]. 2013; 9 (5): 11.17. http://dx.doi.org/10.15360/181397792013511. [In Russ.]
5. Karlsson S., Varpula M., Ruokonen E., Pettila V., Parviainen I., AlaKokkoT.I., Kolho E., Rintala E.M. Incidence, treatment, and outcome of severesepsis in ICUtreated adults in Finland: the Finnsepsis study. Intensive Care Med. 2007; 33 (3): 435.443. http://dx.doi.org/10.1007/s00134 0060504z. PMID: 17225161
6. Blanco J., MurielBombin A., Sagredo V., Taboada F., Gandia F., Tamayo L., Collado J., GarciaLabattut A., Carriedo D., Valledor M., De Frutos M., Lopez M.J., Caballero A., Guerra J., Alvarez B., Mayo A., Villar J.; Grupo de Estudios y Analisis en Cuidados Intensivos. Incidence, organdysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit. Care. 2008; 12 (6): R158. http://dx.doi.org/10.1186/cc7157. PMID: 19091069
7. Nekhaev I.V. Sepsis v torakoabdominalnoi khirurgii. [Sepsis in thora coabdominal surgery]. Moscow: ABVpress; 2011: 6.16. [In Russ.]
8. Strachunsky L.S., Belousov Yu.B., Kozlov S.N. Prakticheskoe rukovodstvo po antibakterialnoi terapii. [Practice guidelines for antibacterial therapy]. Moscow; 2013. [In Russ.]
9. Anisimova N.Yu., Kiselevsky M.V., Gromova E.G., Kuznetsova L.S. Selektivnaya i neselektivnaya gemosorbtsiya v intensivnoi terapii onkologicheskikh bolnykh s tyazhelym sepsisom. [Selective and nonselective hemosorption during intensive care of cancer patients with severe sepsis]. Meditsinsky Alfavit. 2011; 4 (18): 29.33. [In Russ.]
10. Sevin B.U., Ramos R., Lichtinger M., Girtanner R.E., Averette H.E. Antibiotic prevention of infections complicating radical abdominal hysterectomy. Obstet. Gynecol. 1984; 64 (4): 539.545. PMID: 6384850 11. Savelyev V.S., Gelfand B.R., Gologorsky V.A. Sepsis v khirurgii: sostoy anie problemy. [Sepsis in surgery: stateoftheart]. Vrach. 2000; 10: 3.7. [In Russ.]
11. Incle „R. The microcirculation is the motor of sepsis. Crit. Care. 2005; 9 (Suppl 4): S13.S19. PMID: 16168069
12. Mizock „B.A. Redox pairs, tissue hypoxia, organ dysfunction, and mortality. Crit. Care M„ud. 2002; 28 (1): 270.272. http://dx.doi.org/10. 1097/0000324620000100000056. PMID: 10667546
13. Bhor V.M., Thomas C.J., Surolia N., Surolia A. Polymyxin B: an ode to an oldantidote for endotoxin shock. Mol. Biosyst. 2005; 1 (3): 213.222. PMID: 16880985
14. Akira S., Takeda K. Tolllike receptor signaling. Nat. Rev. Immunol. 2004; 4 (7): 499.511. http://dx.doi.org/10.1038/nri1391. PMID: 15229469
15. Takeda K. Evolution and integration of innate immune recognition systems: the Tolllike receptors. J. Endotoxin. Res. 2005; 11 (1): 51.55. http://dx.doi.org/10.1177/09680519050110011101. PMID: 15826379
16. Marshall J.C., Foster D., Vincent J.L., Cook D.J., Cohen J., Dellinger R.P., Opal S., Abraham E., Brett S.J., Smith T., Mehta S., Derzko A., Romaschin A.; MEDIC study. Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J. Infect. Dis. 2004; 190 (3): 527.534. http://dx.doi.org/10.1086/422254. PMID: 15243928
17. Cruz D.N., Perazella M.A., Bellomo R., de Cal M., Polanco N., Corradi V., Lentini P., Nalesso F., Ueno T., Ranieri V.M., Ronco C. Effectiveness of polymyxin Bimmodilized fiber column in sepsis: a systematic review. Crit. Care. 2007; 11 (2): R47. PMID: 17448226
18. Cruz D.N., Antonelli M., Fumagalli R., Foltran F., Brienza N., Donati A., Malcangi V., Petrini F., Volta G., Bobbio Pallavicini F.M., Rottoli F., Giunta F., Ronco C. Early use of polymyxin Bhemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA. 2009; 301 (23): 2445.2452. http://dx.doi.org/10. 1001/jama.2009.856. PMID: 19531784
19. Nakamura T., Matsuda T., Suzuki Y., Shoji H., Koide H. Polymyxin B immobilized fiber hemoperfusion in patients with sepsis. Dial. Transplant. 2003; 32: 602.607.
20. Nemoto H., Nakamoto H., Okada H., Sugahara S., Moriwaki K., Arai M., Kanno Y., Suzuki H. Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis. Blood Purif. 2001; 19 (4): 361.368. http://dx.doi.org/10.1159/000046966. PMID: 11574732
21. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., Sevransky J.E., Sprung C.L., Douglas I.S., Jaeschke R., Osborn T.M., Nunnally M.E., Townsend S.R., Reinhart K., Kleinpell R.M., Angus D.C., Deutschman C.S., Machado F.R., Rubenfeld G.D., Webb S.A., Beale R.J., Vincent J.L., Moreno R.; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for manangement of severe sepsis and septic shock: 2012. Crit. Care Med. 2013; 41 (2): 580.637. http://dx.doi.org/10.1097/CCM.0b013e31827e83af. PMID: 23353941
22. Romaschin A.D., Harris D.M., Ribeiro M.B., Paice J., Foster D.M.,Walker P.M., Marshall J.C. A rapid assay of endotoxin in whole blood using autologous neutrophildependent chemiluminescence. J. Immunol. Methods. 1998; 212 (2): 169.185. http://dx.doi.org/10.1016/S0022 1759(98)000039. PMID: 9672205
Review
For citations:
Ushakova N.D., Shevchenko A.N., Chetverikov M.V., Zlatnik E.Yu., Zykova T.A. Results of Using Selective Endotoxin Adsorption in Cancer Patients with Sepsis. General Reanimatology. 2014;10(6):32-38. https://doi.org/10.15360/1813-9779-2014-6-32-38